CLINICAL AND PHARMACOKINETIC COMPARISON OF CEFUROXIME SODIUM AND CEFUROXIME LYSINE IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONSHAVARD CWH; FERNANDO A; BANNISTER B et al.1981; J. ANTIMICROB. CHEMOTHER.; ISSN 0305-7453; GBR; DA. 1981; VOL. 8; NO 5; PP. 401-408; BIBL. 11 REF.Article

Antibioprophylaxie en chirurgie ophtalmologique. À propos des recommandations de l'AFSSAPS = Antibioprophylaxis in ocular surgery: AFSSAPS recommendationsCOCHEREAU, I; KOROBELNIK, J.-F; ROBERT, P.-Y et al.Journal français d'ophtalmologie. 2011, Vol 34, Num 6, pp 428-430, issn 0181-5512, 3 p.Article

Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroximeRUIZ-CARRETERO, P; MERINO-SANJUAN, M; NACHER, A et al.European journal of pharmaceutical sciences. 2004, Vol 21, Num 2-3, pp 217-223, issn 0928-0987, 7 p.Article

Pharmacokinetics of Cefuroxime in Traumatic Wound Secretion and Antibacterial Activity Under Vacuum TherapyBISCHOFF, M; BECK, A; FREI, P et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 2, pp 92-97, issn 1120-009X, 6 p.Article

ANTIBACTERIAL ACTIVITY OF CEFUROXIME, A NEW CEPHALOSPORIN ANTIBIOTIC, COMPARED WITH THAT OF CEPHALORIDINE, CEPHALOTHIN, AND CEFAMANDOLEEYKYN S; JENKINS C; KING A et al.1976; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1976; VOL. 9; NO 4; PP. 690-695; BIBL. 4 REF.Article

PARADOXICAL EFFECT OF CEFUROXIMECHATTOPADHYAY B.1979; J. ANTIMICROB. CHEMOTHERAPY; GBR; DA. 1979; VOL. 5; NO 3; PP. 325-326; BIBL. 5 REF.Article

Saliva and Blood Concentration of Cefuroxime in Patients Undergoing Maxillofacial SurgeryVENETIS, Gregory; CHATZIKA, Kalliopi; PITSIOU, Georgia et al.Journal of oral and maxillofacial surgery. 2012, Vol 70, Num 6, pp 1398-1403, issn 0278-2391, 6 p.Article

Column and thin-layer chromatographic methods for the simultaneous determination of acediasulfone in the presence of cinchocaine, and cefuroxime in the presence of its hydrolytic degradation productsABDUL-AZIM MOHAMMAD, Mohammad; ZAWILLA, Nagwan H; EL-ANWAR, Fawzy M et al.Journal of AOAC International. 2007, Vol 90, Num 2, pp 405-413, issn 1060-3271, 9 p.Article

CEFAMANDOLE, CEFUROXIME AND CEFOXITIN1979; DRUG THERAPEUT. BULL.; GBR; DA. 1979; VOL. 17; NO 9; PP. 35-36; BIBL. 22 REF.Article

Development and validation of a microbiological agar assay for determination of cefuroxime sodium in pharmaceutical preparationsSCHMIDT, Cleber A; AGARRAYUA, Danielle A; LAPORTA, Luciane V et al.Journal of microbiological methods. 2009, Vol 77, Num 3, pp 308-315, issn 0167-7012, 8 p.Article

PELVIC TISSUE LEVELS OF CEFUROXIMEPRITCHARD JM; ELDER MG; KENNEDY MRK et al.1981; J. INFECT.; ISSN 0163-4453; GBR; DA. 1981; VOL. 3; NO 2; PP. 193-194; BIBL. 4 REF.Article

Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailabilityDHUMAL, Ravindra S; BIRADAR, Shailesh V; YAMAMURA, Shigeo et al.European journal of pharmaceutics and biopharmaceutics. 2008, Vol 70, Num 1, pp 109-115, issn 0939-6411, 7 p.Article

The stability of the amorphous form of cefuroxime axetil in solid stateJELINSKA, Anna; DUDZINSKA, Izabela; ZAJAC, Marianna et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 3, pp 1075-1081, issn 0731-7085, 7 p.Article

A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal functionVIBERG, Anders; LANNERGARD, Anders; LARSSON, Anders et al.British journal of clinical pharmacology. 2006, Vol 62, Num 3, pp 297-303, issn 0306-5251, 7 p.Article

Effect of the freezing conditions and microwave thawing power on the stability of cefuroxime in dextrose 5% infusion polyolefin bags at 4 °CHECQ, Jean-Daniel; BOITQUIN, Laurence P; VANBECKBERGEN, Danielle F et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 7-8, pp 1244-1248, issn 1060-0280, 5 p.Article

Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanateSADER, Helio S; JACOBS, Michael R; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 3S, issn 0732-8893, 5S-12S, SUPArticle

PHARMACOKINETICS OF INTRAVENOUS AND INTRAPERITONEAL CEFUROXIME DURING PERITONEAL DIALYSISLA GRECA G; BIASIOLI S; CHARAMONTE S et al.1982; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1982; VOL. 20; NO 2; PP. 92-94; BIBL. 6 REF.Article

ZINACEF. = ZINACEFHOFSTETTER A.1978; UROLOGE, A; DTSCH.; DA. 1978; VOL. 17; NO 3; PP. 201-202; BIBL. 15 REF.Article

Pharmacology of cefuroxime as the 1-acetoxyethyl ester in volunteersHARDING, S. M; WILLIAMS, P. E. O; AYRTON, J et al.Antimicrobial agents and chemotherapy. 1984, Vol 25, Num 1, pp 78-82, issn 0066-4804Article

Les céphalosporines orales: place du céfuroxime-axetil = Oral cephalosporins: evaluation of cefuroxime-axetilBERGOGNE-BEREZIN, E.Thérapie (Paris). 1988, Vol 43, pp 343-349, issn 0040-5957, suppl. au no 4Article

Correlation of cefpodoxime susceptibility with cephalothin and cefuroxime for urinary tract isolatesBOOKSTAVER, David A; BLAND, Christopher M; WOODBERRY, Mitchell W et al.Journal of medical microbiology. 2014, Vol 63, Num 2, pp 218-221, issn 0022-2615, 4 p.Article

CEFUROXIME CONCENTRATIONS IN PERICARDIAL FLUIDMARTINI N; XERRI L; PUCHETTI V et al.1981; J. ANTIMICROB. CHEMOTHER.; ISSN 0305-7453; GBR; DA. 1981; VOL. 7; NO 1; PP. 107-109; BIBL. 7 REF.Article

ANTIBACTERIAL ACTIVITY OF CEFUROXIME IN AN IN VITRO PHARMACOKINETIC MODELXERRI L; ORSOLINI P; BROGGIO R et al.1981; DRUGS EXP. CLIN. RES.; ISSN 0378-6501; CHE; DA. 1981; VOL. 7; NO 4; PP. 459-464; BIBL. 5 REF.Article

ANTIMICROBIAL ACTIVITY AND SYNERGISM OF CEFUROXIME ON ANAEROBIC BACTERIATHADEPALLI H; WHITE DW; BACH VT et al.1981; CHEMOTHERAPY (BASEL); ISSN 0009-3157; CHE; DA. 1981; VOL. 27; NO 4; PP. 252-258; BIBL. 18 REF.Article

CEFUROXIME IN URINARY TRACT INFECTIONCOPLAND RFP; MUENCH R.1980; PRAXIS; CHE; DA. 1980; VOL. 69; NO 21; PP. 742-746; ABS. GER/FRE; BIBL. 7 REF.Article